Helen L Collins

This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Five Prime Therapeutics, Inc.. Active years: 2021-2026.

USPTO Granted Patents = 3 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

3 out of 77

Five Prime Therapeutics, Inc.

patents

Years Active: 2021-2026

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697385 - COMBINATION THERAPY FOR CANCER WITH ANTI-B7-H4 ANTIBODIES AND ANTI-PD-1 ANTIBODIES (2026-08-04),

2. 12319738 - Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer (2025-06-03),

3. 11091555 - Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy (2021-08-17),

Profile summary based on public USPTO records.